Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMPASS Pathways plcCMPS · Entity 4567 | Director | May 27, 2026 | May 29, 2026 |
| HCA Healthcare, Inc.HCA · Entity 2929 | Director | April 28, 2026 | April 30, 2026 |
| Heartflow, Inc.HTFL · Entity 3993 | Director | June 16, 2026 | June 18, 2026 |
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | June 01, 2015 | June 03, 2015 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMPASS Pathways plc
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.85 · Expires 2036-05-26 | Direct | 21,110 |
Reported balance
After 2026-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 21,110 · Balance 21,110 F1: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027. F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.
F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
HCA Healthcare, Inc.
Report date April 28, 2026 · Filed April 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,029 |
Reported balance
After 2026-04-28 transaction · row 1
1 source rowRow 1 · 2026-04-28 · Grant · Acquired 509 · Balance 15,029 F1: Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.
Heartflow, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $32.05 · Expires 2036-06-16 | Direct | 16,075 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 16,075 · Balance 16,075 F1: The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.
VERTEX PHARMACEUTICALS INC / MA
Report date June 01, 2015 · Filed June 03, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $127.54 · Expires 2025-05-31 | Direct | 20,000 |
Reported balance
After 2015-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2015-06-01 · Grant · Acquired 20,000 · Balance 20,000 F1: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 21:27 UTC | Heartflow, Inc. HTFL · Entity 3993 | GrantStock Option · Derivative | 16,075 | $32.05 Strike: $32.05 | $515,203.75 |
DisclosureSEC source: 0001464521-26-000087 · form4.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,075 Underlying: Common Stock · 16,075 shares Expires 2036-06-16 F1 · derivative.exercise_date: The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:13 UTC | COMPASS Pathways plc CMPS · Entity 4567 | GrantShare Option (Right to Buy) · Derivative | 21,110 | $0.00 Strike: $11.85 | $0.00 |
DisclosureSEC source: 0001432895-26-000002 · wk-form4_1780089227.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,110 Underlying: Ordinary Shares · 21,110 shares Expires 2036-05-26 F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 17:04 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-197773 · ownership.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,029 F1 · kind: Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:01 UTC | Heartflow, Inc. HTFL · Entity 3993 | GrantStock Option · Derivative | 23,710 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039736 · wk-form4_1754960479.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,710 Underlying: Common Stock · 23,710 shares Expires 2035-08-07 F1 · derivative.exercise_date: The option will vest in full on the earlier of Heartflow, Inc.'s annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 12:27 UTC | COMPASS Pathways plc CMPS · Entity 4567 | GrantShare Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001816590-25-000081 · wk-form4_1749817660.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 26,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 29, 2025 Filed May 1, 2025 18:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 645 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-062139 · ownership.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,520 F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| May 09, 2024 Filed May 13, 2024 10:47 UTC | COMPASS Pathways plc CMPS · Entity 4567 | GrantShare Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $8.54 | $0.00 |
DisclosureSEC source: 0001816590-24-000100 · wk-form4_1715597234.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 26,000 shares Expires 2034-05-08 F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2025. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 29, 2024 Filed May 1, 2024 18:21 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-005450 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,875 F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:29 UTC | COMPASS Pathways plc CMPS · Entity 4567 | GrantShare Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $7.88 | $0.00 |
DisclosureSEC source: 0001816590-23-000089 · wk-form4_1686083355.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 26,000 shares Expires 2033-06-01 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual Meeting of Shareholders in 2024. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 17:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 663 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025709 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,265 F1 · kind: Represents common stock underlying 663 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2024 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:11 UTC | COMPASS Pathways plc CMPS · Entity 4567 | GrantShare Option (Right to Buy) · Derivative | 21,250 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0001816590-22-000058 · wf-form4_165549665774680.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 Underlying: Ordinary Shares · 21,250 shares Expires 2032-06-15 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual Meeting of Shareholders in 2023. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:34 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025876 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,602 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:37 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029403 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 19:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,650 | $190.00 | $313,500.00 |
DisclosureSEC source: 0001209191-21-019639 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,819 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,650 | $175.00 | $288,750.00 |
DisclosureSEC source: 0001209191-21-008359 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,469 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,650 | $166.19 | $274,213.50 |
DisclosureSEC source: 0001209191-21-008359 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,119 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:04 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027346 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,769 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the Issuer's 2021 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| May 01, 2019 Filed May 3, 2019 17:06 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027451 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,101 F1 · kind: Represents common stock underlying 1,410 restricted share units which shall vest on the sooner of the date of the Issuer's 2020 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| May 02, 2018 Filed May 4, 2018 17:17 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028164 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,691 F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| May 03, 2017 Filed May 5, 2017 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 2,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030327 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,901 F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 15, 2017 00:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,500 | $84.00 | $210,000.00 |
DisclosureSEC source: 0001209191-17-010825 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,789 Read SEC document |
| June 01, 2015 Filed Jun 3, 2015 20:43 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $127.54 | $0.00 |
DisclosureSEC source: 0001209191-15-049636 · doc4.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-05-31 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| March 20, 2015 Filed Mar 24, 2015 21:59 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $59.55 | $0.00 |
DisclosureSEC source: 0001209191-15-028961 · doc4.xml · derivative · entry 3 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2022-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 20, 2015 Filed Mar 24, 2015 21:59 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $135.08 | $1,350,800.00 |
DisclosureSEC source: 0001209191-15-028961 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. Read SEC document |
| March 20, 2015 Filed Mar 24, 2015 21:59 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $59.55 | $595,500.00 |
DisclosureSEC source: 0001209191-15-028961 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2015 Filed Jan 13, 2015 21:19 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $53.85 | $0.00 |
DisclosureSEC source: 0001209191-15-003892 · doc4.xml · derivative · entry 3 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| January 09, 2015 Filed Jan 13, 2015 21:19 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $125.00 | $1,250,000.00 |
DisclosureSEC source: 0001209191-15-003892 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. Read SEC document |
| January 09, 2015 Filed Jan 13, 2015 21:19 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $53.85 | $538,500.00 |
DisclosureSEC source: 0001209191-15-003892 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2014 Filed Oct 23, 2014 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $53.85 | $0.00 |
DisclosureSEC source: 0001209191-14-064489 · doc4.xml · derivative · entry 3 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| October 21, 2014 Filed Oct 23, 2014 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $110.00 | $1,100,000.00 |
DisclosureSEC source: 0001209191-14-064489 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · kind: Transaction made pursuant to Mr. Riley's company approved trading plan under Rule 10b5-1. Read SEC document |
| October 21, 2014 Filed Oct 23, 2014 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $53.85 | $538,500.00 |
DisclosureSEC source: 0001209191-14-064489 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2014 Filed Aug 19, 2014 20:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 200 | $0.00 Strike: $33.89 | $0.00 |
DisclosureSEC source: 0001209191-14-053404 · doc4.xml · derivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200 shares Expires 2020-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| August 15, 2014 Filed Aug 19, 2014 20:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 200 | $33.89 | $6,778.00 |
DisclosureSEC source: 0001209191-14-053404 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2014 Filed Jul 17, 2014 22:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 4,800 | $0.00 Strike: $33.89 | $0.00 |
DisclosureSEC source: 0001209191-14-047905 · doc4.xml · derivative · entry 5 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Underlying: Common Stock · 4,800 shares Expires 2020-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| July 15, 2014 Filed Jul 17, 2014 22:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 292 | $98.17 | $28,665.64 |
DisclosureSEC source: 0001209191-14-047905 · doc4.xml · nonDerivative · entry 4 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $98.17 (range $98.02 to $98.30). Read SEC document |
| July 15, 2014 Filed Jul 17, 2014 22:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,016 | $97.02 | $195,592.32 |
DisclosureSEC source: 0001209191-14-047905 · doc4.xml · nonDerivative · entry 3 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $97.02 (range $96.66 to $97.57). Read SEC document |
| July 15, 2014 Filed Jul 17, 2014 22:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,492 | $96.17 | $239,655.64 |
DisclosureSEC source: 0001209191-14-047905 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,508 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $96.17 (range $95.63 to $96.62). F3 · price: Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 15, 2014 Filed Jul 17, 2014 22:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 4,800 | $33.89 | $162,672.00 |
DisclosureSEC source: 0001209191-14-047905 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 20:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $33.89 | $0.00 |
DisclosureSEC source: 0001209191-14-043878 · doc4.xml · derivative · entry 3 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 15,000 shares Expires 2020-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 7/9/2010. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 20:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 15,000 | $98.03 | $1,470,450.00 |
DisclosureSEC source: 0001209191-14-043878 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 20:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 15,000 | $33.89 | $508,350.00 |
DisclosureSEC source: 0001209191-14-043878 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2014 Filed Jun 3, 2014 20:15 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $72.14 | $0.00 |
DisclosureSEC source: 0001209191-14-038666 · doc4.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2024-05-31 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| July 29, 2013 Filed Jul 31, 2013 20:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $33.89 | $0.00 |
DisclosureSEC source: 0001209191-13-038501 · doc4.xml · derivative · entry 4 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2020-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/09/2010. Read SEC document |
| July 29, 2013 Filed Jul 31, 2013 20:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 100 | $81.18 | $8,118.00 |
DisclosureSEC source: 0001209191-13-038501 · doc4.xml · nonDerivative · entry 3 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 29, 2013 Filed Jul 31, 2013 20:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 9,700 | $80.08 | $776,776.00 |
DisclosureSEC source: 0001209191-13-038501 · doc4.xml · nonDerivative · entry 2 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $80.08 (range $80.00 to $80.92). F3 · price: Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 29, 2013 Filed Jul 31, 2013 20:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $33.89 | $338,900.00 |
DisclosureSEC source: 0001209191-13-038501 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2013 Filed Jun 4, 2013 20:20 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0001209191-13-030496 · doc4.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2023-05-31 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 01, 2012 Filed Jun 1, 2012 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $59.55 | $0.00 |
DisclosureSEC source: 0001209191-12-031710 · doc4.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2022-05-31 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 01, 2011 Filed Jun 2, 2011 20:43 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $53.85 | $0.00 |
DisclosureSEC source: 0001209191-11-032542 · doc4.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2021-05-31 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| July 09, 2010 Filed Jul 13, 2010 20:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Options · Derivative | 30,000 | $0.00 Strike: $33.89 | $0.00 |
DisclosureSEC source: 0000875320-10-000039 · edgar.xml · derivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2020-07-08 F1 · shares: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments over four years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.